Member Info for Jimzi

Jiddy mate, you seem very bitter today . They probably haven’t replied cause there’s only one employee left after the cost cuts. Cheer up, the RNS today was very good

well, you can sell 500k at the bid

Shows you the auto's just playing with their own shares whilst winkling

Chinese funding - proactive article I posted here a couple of weeks ago - just go back and you'll find it.

Your right with todays news being amazing - but its not a one product co - 3 big ones and I think 4 incubator ones.

With repsect, Jiddy and I were having decent chats prior to today - its the bagging in a day etc that is annoying - as it attracts 4 hour kiddies who sell at a loss and then moan [and then put off others]

You seem like a more intelligent bloke so its good the holder base has been widened a bit

FYI, lots of peeps sold after the results - such results saying funded for 18 months, all investments self financing and bordering onto commercial commencement - all with a NAV of 20p pre today.

Ergo, we are here cause few know about it.

just remember, Iclaprim is the only AB under development that kills the bacteria so no resistance - deaths in the US from resistance? 100,000.

We all think the FDA are badies - not so sure they are - just covering their behinds and want post market surveillance - that way its on the market but they have covered their aforementioned botty's.imo

Its coming to market as its needed - if you can't take a punt on that, then don't bother with AIM [or post on AIM shares]

Eye guy your missing the point here - Glycotest, Inc. is worth 1.5 times the current mcap on its own - thats without todays news and the other investments.

Funded for 18 months and 7m free float -it ain't rocket science. Its a rarity but many can't see it. Value will prevail some day

Looks as if all the newbies have now left - time to get a few more soon.

Determine what $ amount you are prepared to lose, assume it drops to 4p worse case and buy the number of shares accordingly.

Then you won't have to keep posting these inane repetitive posts

In calculating NAV last week, I attibuted only 1m quid to Proaxis as sod all info to give a value.

Changed today in a big way.

Could be very valuable IP and nice license deals to come - it appears ready for market.

Thats why NSCI is good - none of the FDA trials and rejections that have crippled many AIMers.

I'm sure not many are interested in this as for many its a day trade - but if you did buy at 12p - don't worry, it will re-rate in good time.- top up when the 10 percenters exit which they are atm.- only 30k of shares were bought below 10p on opening.

If you look at the results and posts here, you will see this is one share where it isn't a casino.
Clean, self financing investments - much higher NAV than mcap [before todays RNS].

Downside, so few shares, volatile as hell.

Cheers gents Would suggest de list is temporary though

why is the mcap so low when in 2018 they generated $34m cash [and EBITDA the same]?
Cheers

Seem to remember ages ago there were a load of cheap warrants - no idea - just a thought.

This co will break out. No idea when though as not does anyone else. That’s investing.

They don't Ian - they've just topped up their CD.
Its not bad nor is it a vote of confidence - its a leveraged punt.

If you look at the Gates Foundation site and mission, HVO activities fit like a glove for both big ticket projects.

Surely the BOD should approach Bill - it removes the cash/greed element of any deal negs that is possibly holding this back somewhat.
Grant/loan/equity - negotiate away imo. Welcome used to do it!

Of course its punt money - its a CFD for $320k of stock - being on margin - thats less than $100k and they manage billions.

Just keep it real & balanced

Key bit of RNS which it all hinges on: [from post meeting RNS]

Additional data likely will be required to address the Agency's concern about a risk of liver toxicity, the size and scope of which will determine the specific next steps

So Doc, your being a bit over enthusiastic.
Its certainly not plain sailing but at this mcap its a decent risk reward play.

Yes and no. Yes for us bored buggers but no as they only RNS when necessary and on the business front - no adverse news for ages, in fact its all been great.

Too many vague RNS [esp Rs] and generally it spells trouble but a bit more indicative commentary may stop the impatient PIs selling.but as most are holding for major news, its largely irrelevant.

Just noticed SCLP down 9.5% today for no apparent reason

PS - you can sell 300k for 20.1p so not all doom and gloom.